Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionVirtue Capital Management, LLC
Latest Disclosed Ownership2,928 shares
Latest Disclosed Value $ 399,204
Virtue Capital Management, LLC reports 48.33% increase in ownership of GILD / Gilead Sciences, Inc.

On May 7, 2026 - Virtue Capital Management, LLC filed a 13F-HR form disclosing ownership of 2,928 shares of Gilead Sciences, Inc. (CH:GILD) valued at $399,204 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 18, 2026 disclosing 1,974 shares of Gilead Sciences, Inc.. This represents a change in shares of 48.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,928 954 48.33 399 66.25 0.0607
2026-02-18 2025-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,974 1,974 240 0.0370
2026-02-12 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,974 1,974 240 0.0370
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 0 -5,362 -100.00 0 -100.00
2024-02-15 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,362 -2,667 -33.22 448 -27.90 0.0908
2023-11-14 2023-09-30 13F GILEAD SCIENCES INC COM COM 375558103 8,029 0 0.00 620 0.00 0.1056
2023-07-18 2023-06-30 13F GILEAD SCIENCES INC COM COM 375558103 8,029 1,470 22.41 620 12.93 0.1058
2023-05-11 2023-03-31 13F GILEAD SCIENCES INC COM COM 375558103 6,559 -1,462 -18.23 549 -20.20 0.0899
2023-02-10 2022-12-31 13F GILEAD SCIENCES INC COM COM 375558103 8,021 8,021 689 0.1051
2022-11-15 2022-09-30 13F GILEAD SCIENCES INC COM COM 375558103 0 -4,533 -100.00 0 -100.00
2022-08-10 2022-06-30 13F GILEAD SCIENCES INC COM COM 375558103 4,533 -2,582 -36.29 280 -33.81 0.0440
2022-05-16 2022-03-31 13F GILEAD SCIENCES INC COM COM 375558103 7,115 -3,554 -33.31 423 -45.42 0.0666
2022-01-24 2021-12-31 13F GILEAD SCIENCES INC COM COM 375558103 10,669 1,643 18.20 775 23.02 0.1143
2021-11-12 2021-09-30 13F GILEAD SCIENCES INC COM COM 375558103 9,026 -714 -7.33 630 -6.11 0.1116
2021-07-15 2021-06-30 13F GILEAD SCIENCES INC COM COM 375558103 9,740 -2,270 -18.90 671 -13.53 0.1340
2021-05-13 2021-03-31 13F GILEAD SCIENCES INC COM COM 375558103 12,010 520 4.53 776 15.99 0.1826
2021-02-16 2020-12-31 13F GILEAD SCIENCES INC COM COM 375558103 11,490 -2,290 -16.62 669 -23.19 0.1641
2020-11-16 2020-09-30 13F GILEAD SCIENCES INC COM COM 375558103 13,780 -3,038 -18.06 871 -32.69 0.2144
2020-08-10 2020-06-30 13F GILEAD SCIENCES INC COM COM 375558103 16,818 16,818 1,294 0.2985
2020-05-13 2020-03-31 13F GILEAD SCIENCES INC COM COM 375558103 0 -8,921 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GILEAD SCIENCES INC COM COM 375558103 8,921 -4,381 -32.93 580 -31.20 0.1673
2019-11-12 2019-09-30 13F GILEAD SCIENCES INC COM COM 375558103 13,302 -1,878 -12.37 843 -17.84 0.2781
2019-11-12 2019-06-30 13F GILEAD SCIENCES INC COM COM 375558103 15,180 15,180 1,026 0.3730
2019-02-13 2018-12-31 13F Gilead Sciences COM 375558103 0 -30,086 -100.00 0 -100.00
2019-02-13 2018-09-30 13F GILEAD SCIENCES INC COM COM 375558103 30,086 14,982 99.19 2,323 117.10 0.4908
2018-08-14 2018-06-30 13F Gilead Sciences COM 375558103 15,104 2,255 17.55 1,070 12.51 0.5201
2018-05-15 2018-03-31 13F GILEAD SCIENCES INC COM COM 375558103 12,849 1,012 8.55 951 12.15 0.5010
2018-02-14 2017-12-31 13F Gilead Sciences com 375558103 11,837 11,837 848 0.4822
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.